19937 results for «»

Filter By

19937 results

Is only fixing functional mitral regurgitation in heart failure patients enough?

20 Nov 2023 – From PCR London Valves 2023

This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.

Is only fixing functional mitral regurgitation in heart failure patients enough?

A new angiographic tool to evaluate stent expansion besides intracoronary imaging

24 Nov 2023

A 57-year-old man with hypertension and dyslipidemia as cardiovascular risk factors was admitted for stable angina for months. His symptoms were not controlled despite maximal medical treatment (beta-blockers, nitrates, aspirin, statins). Angios revealed multivessel disease. How would you manage this case?

Author

Salvatore Brugaletta
3DStent: a new tool to evaluate stent expansion besides intra-coronary imaging

Essentials of lifetime management of TAVI patients

20 Nov 2023 – From PCR London Valves 2023

In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.

Essentials of lifetime management of TAVI patients

Expert roundtable: 4D ICE in tricuspid interventions

20 Nov 2023 – From PCR London Valves 2023

Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...

Expert roundtable: 4D ICE in tricuspid interventions

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

Enjoy new step-by-step and hands-on training at #PCRLV 2022!

With the Simulation Based Learning Pathway, watch the experts, learn by doing, then enjoy more hands-on practice in the Training Village!
Hands-on!

PCR Tricuspid Focus Group – Referral meeting calendar

12 Oct 2023

Discover what took place during previous referral meetings, and prepare yourself for future ones!

 

Since 2023, the PCR Tricuspid Focus Group has been dedicated to raising awareness about tricuspid valve disease among healthcare professionals and has endorsed a total of 25 local referral meetings to date.

A referral...

PCR Tricuspid Focus Group – Referral meeting calendar

PCR London Valves 2023 - Training Village Programme

  • Updated in real time, Programme times shown are London time (GMT).
.list-filter, .programme-list {display: none!important;} .iframe-programme {width: 100%;min-width: 100%;border:none;height:2000px;} .iframe-wrapper {margin-top: 50px;overflow: auto;-webkit-overflow-scrolling:touch;} const programmeUrl = 'https://interactive-programme.europa-organisation.com/pcrlondon2023/iframe_pcronline_training.php'; function programmeIframe(iframeURL) {   const urlParams = new URLSearchParams(window.location.search).toString();   const iframeProgramme = document.getElementById('iframeProgramme');   if (urlParams)     iframeURL += '?' + urlParams;   iframeProgramme.src = iframeURL;   const myEmbed =...
Get an overview of what’s in store!

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

03 Nov 2023

Dive into the PCR Imaging Valves Madrid 2024 Workshop Programme!

Find out what’s happening and when at PCR Imaging Valves Madrid 2024
Discover the full PCR Imaging Valves Madrid 2024 Workshop Programme

The unimaginable evolution of interventional cardiology from imagination to imaging

07 Nov 2023

Faith is to believe what you do not see; the reward of this faith is to see what you believe... Read this editorial by Flavio Ribichini, Martine Gilard and Salvatore Brugaletta which introduces this section dedicated to cardiovascular imaging. ...

The unimaginable evolution of interventional cardiology from imagination to imaging

AHA 2023: get the interventional cardiology perspective!

11 Nov 2023

Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.

PCRonline @ AHA 2023

ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial

12 Nov 2023

Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Christopher Rajkumar

Author

Christopher Rajkumar
Rasha Al-Lamee

Author

Rasha Al-Lamee
ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

15 Nov 2023

Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.

Author

Aaysha Cader
Peter Sinnaeve

Author

Peter Sinnaeve
Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

Peter Sinnaeve

Leuven, Belgium

Peter Sinnaeve

INDUSTRY PARTNERS HELPED MAKE IT HAPPEN!

Before, during and after EuroPCR, Industry Partners provide precious support with content and initiatives that contribute to making this event the World-Leading Course in Interventional Cardiovascular Medicine.
INDUSTRY PARTNERS HELPED MAKE IT HAPPEN!

Dominic Allocco

Edina, United States of America

Srinivas B C

BANGALORE, India

Mei Chau

New York, United States of America

Didn’t find what you were looking for?